Select Publications

Conference Posters

Storer D; Prestage G; Murphy D; Grulich A; Holt M; Ellard J; Bavinton B; Philpot S; Maher L; Jin F; Saxton P; Batrouney C; Hammoud M, 2021, 'Challenges of recommencing HIV pre-exposure prophylaxis (PrEP) use during the COVID-19 pandemic', Virtual, presented at IAS Conference on HIV Science 2021, Virtual, 18 July 2021

McManus H; Drak D; Heron JE; Vickers T; Vaccher S; Zablotska I; Guy RJ; Bavinton B; Jin F; Grulich AE; Bloch M; O'Connor CC; Gracey D, 2020, 'PrEP DRUG RESISTANCE AND RENAL IMPAIRMENT', presented at Conference on Retroviruses and Opportunistic Infections, 08 March 2020, https://www.croiconference.org/abstract/renal-impairment-in-a-preexposure-prophylaxis-implementation-cohort-in-australia/

Vaccher S; Holt M; Prestage G; Amin J; Selvey C; Zablotska-Manos I; Guy R; Jin F; Carr A; Grulich A; Bavinton B, 2019, 'Methamphetamine users in the EPIC-NSW study report high adherence to pre-exposure prophylaxis (PrEP)', Perth, Western Australia, presented at Australian HIV and AIDS Conference, Perth, Western Australia, 17 September 2019, https://az659834.vo.msecnd.net/eventsairaueprod/production-ashm-public/965b72bcb63f490083f4c0b91255431c

Vaccher S; Guy R; Templeton D; Zablotska-Manos I; Clackett S; Holt M; Prestage G; Amin J; Selvey C; Jin F; Grulich A; Bavinton B, 2019, 'Pre-exposure prophylaxis use among trans and gender diverse people: Characteristics and behaviour from the EPIC-NSW trial', Vancouver, Canada, presented at STI & HIV World Congress, Vancouver, Canada, 14 July 2019

Vaccher S; Grulich A; Haire B; Templeton D; McNulty A; Foster R; Ooi C; Poynten M; Prestage G; Zablotska-Manos I, 2018, 'High adherence to HIV PrEP among clinic attendees over 12 months in the PRELUDE open-label demonstration project', Canberra, Australia, presented at Australian HIV and AIDS Conference, Canberra, Australia, 06 November 2018

Vaccher S; Marzinke M; Grulich AE; Ooi C; Carr A; Haire BG; Selvey C; Templeton DJ; Holt M; Crooks L; Zablotska I, 2017, 'High adherence to HIV pre-exposure prophylaxis (PrEP) in participants presenting for month 12 visit in PRELUDEopen-label study in NSW, Australia', Paris, France, presented at International AIDS Society, Paris, France, 23 July 2017 - 26 July 2017, http://programme.ias2017.org/Abstract/Abstract/3358

Vaccher SJ; Grulich A; Prestage G; Bavinton B; Zablotska-Manos I, 2016, 'Use of behavioural eligibility criteria to identify high-HIV risk gay and bisexual men (GBM) for enrolment in a pre-exposure prophylaxis (PrEP) study in NSW, Australia', Durban, South Africa, presented at AIDS 2016, Durban, South Africa, 16 July 2016 - 21 July 2017

Vaccher S; Prestage G; McNulty A; Carr A; Holden J; Schmidt H-M; Holt M; Ooi C; Templeton D; Poynten M; Grulich A; Zablotska-Manos I, 2015, 'Characteristics of Gay Men in Sydney using HIV Pre-Exposure Prophylaxis (PrEP): Baseline Data from the PrELUDE Study', Brisbane, Australia, presented at Australian HIV and AIDS Conference, Brisbane, Australia, 16 September 2015

Yeung A; Caruana T; Grulich A; de Visser R; Rissel C; Simpson J; Richters J, 2015, 'P04.15 Sexual behaviour, sti testing and diagnosis down under: findings from the second australian study of health and relationships (ashr2)', Vol. 91, pp. A101.1 - A101, http://dx.doi.org/10.1136/sextrans-2015-052270.269

Templeton DJ; Fin F; Prestage G; Donovan BJ; Imrie JC; Kippax SC; Cunningham AL; Mindel A; Kaldor JM; Grulich AE, 2007, 'Circumcision status and risk of HIV and sexually transmitted infections in the HIM cohort of homosexual men in Sydney, Australia', Madrid, Spain, Vol. 4, pp. 310 - 310, presented at 11th European AIDS Conference (EACS) 2008, Madrid, Spain, 24 October 2007 - 27 October 2007, http://dx.doi.org/10.1071/SHv4n4Ab65


Back to profile page